---
title: "Datt Mediproducts Ltd (DATTMEDI) — Share Price, Financials & Analysis"
symbol: "DATTMEDI"
company: "Datt Mediproducts Ltd"
canonical: "https://tapetide.com/stocks/DATTMEDI"
generated_at: "2026-10-13T11:00:21.404Z"
---

# Datt Mediproducts Ltd (DATTMEDI)

Canonical page: https://tapetide.com/stocks/DATTMEDI

## Company

- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** dattmedi.com

## Latest Price

## Key Insights

### Weaknesses

- Company might be capitalizing the interest cost

## Growth Rates

| Metric | 1Y |
| --- | --- |
| net income growth | -3% |
| revenue growth | 14% |

## Financial Statements

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2014 | Mar 2015 |
| --- | --- | --- |
| Sales | 61.11 | 69.72 |
| Expenses | 56.87 | 64.28 |
| Operating Profit | 4.24 | 5.44 |
| OPM % | 6.94 | 7.8 |
| Other Income | 0.89 | -0.02 |
| Interest | 1.37 | 1.41 |
| Depreciation | 1.99 | 1.94 |
| Profit before tax | 1.77 | 2.07 |
| Tax % | 23.16 | 38.65 |
| Net Profit | 1.36 | 1.27 |
| Dividend Payout % | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2014 | Mar 2015 |
| --- | --- | --- |
| Equity Capital | 13.22 | 13.22 |
| Reserves | 4.87 | 6.14 |
| Borrowings | 24.41 | 26.82 |
| Other Liabilities | 9.81 | 12 |
| Total Liabilities | 52.31 | 58.18 |
| Fixed Assets | 20.52 | 20.42 |
| CWIP | 0.09 | 0.11 |
| Investments | 0.65 | 1.71 |
| Other Assets | 31.05 | 35.94 |
| Total Assets | 52.31 | 58.18 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2014 | Mar 2015 |
| --- | --- | --- |
| Cash from Operating Activity | 1.67 | 3.19 |
| Cash from Investing Activity | -2.15 | -3.44 |
| Cash from Financing Activity | 1.02 | 1.21 |
| Net Cash Flow | 0.54 | 0.96 |
| Free Cash Flow | -0.4 | 0.99 |
| CFO/OP | 39 | 59 |

### Ratios

| Item | Mar 2014 | Mar 2015 |
| --- | --- | --- |
| Debtor Days | 51.19 | 54.87 |
| Inventory Days | 214.89 | 236.61 |
| Days Payable | 50.26 | 60.68 |
| Cash Conversion Cycle | 215.82 | 230.79 |
| Working Capital Days | 122.8 | 120.25 |
| ROCE % | — | 8.04 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 6 / 1 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 42.96 | Sell |
| EMA (10) | 42.26 | Sell |
| SMA (20) | 45.49 | Sell |
| EMA (20) | 45.47 | Sell |
| SMA (50) | 56.42 | Sell |
| EMA (50) | 56.32 | Sell |
| SMA (100) | 75.79 | Sell |
| EMA (100) | 75.04 | Sell |
| SMA (200) | 111.42 | Sell |
| EMA (200) | 104.14 | Sell |

### Oscillators — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 21.14 | Buy |
| MACD (12,26,9) | -4.56 | Sell |
| Stochastic (14,3,3) | 3.04 | Buy |
| ADX (14) | 69.96 | Buy |
| Williams %R (14) | -90.87 | Buy |
| ATR (14) | 2.56 | High Volatility |
| ROC (12) | -19.32 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 24.6 | Buy |

## Filings & Documents

### Credit Rating Reports

| Date | Document |
| --- | --- |
| 2023-09-13 | Credit rating update — India Ratings |
| 2023-08-11 | Credit rating update — Acuité |
| 2022-06-02 | Credit rating update — Acuité |
| 2021-02-27 | Credit rating update — Acuité |
| 2019-12-19 | Credit rating update — Acuité |
| 2018-12-18 | Credit rating update — Acuité |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-10-13T11:00:21.404Z.